Clinical Trials

Ongoing Trials

Healey Center Platform Trial for ALS (Spring 2020)

Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (REFALS)

Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC)

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (CENTAUR) – completed enrollment, no longer recruiting

An up-to-date listing of our studies can be found here

Completed trials

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) (FORTITUDE-ALS)

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (Mexiletine-2)

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year (VITALITY-ALS)

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

For questions on clinical trials at the University of Michigan, please email Jayna Duell at jkballar@med.umich.edu